Comprehensive Forced Degradation Study of Pemigatinib and Structural Elucidation of Its Degradation Products Using Liquid Chromatography–High‐Resolution Mass Spectrometry and Nuclear Magnetic Resonance

Documenti analoghi

• Separation and characterization of hydrolytic degradation product of deucravacitinib by validated high‐performance liquid chromatography method and liquid chromatography‐mass spectrometry
  di: Vijaya Madhyanapu Golla, et al.
  Pubblicazione: (2024)
• Targeted Ultra‐High Performance Liquid Chromatography–Electrospray Ionization Triple Quadrupole Mass Spectrometry‐Based Quantification of Diosgenin in Hellenia speciosa for Its Wild Populations Screening: A Quality Control Assessment
  di: Pankaj Singh, et al.
  Pubblicazione: (2025)
• Comprehensive Analysis of Edaravone Degradation: Isolation and Structural Elucidation of Oxidative Degradation Products via Preparative Chromatography, LC‐MS, and NMR
  di: Bhaskar Vallamkonda, et al.
  Pubblicazione: (2026)
• Reverse‐phase high‐performance liquid chromatography methodology for film‐forming mafenide spray: Compatibility, assay, and in‐vitro release evaluation using Franz vertical diffusion cell apparatus
  di: Rupali Mahajan, et al.
  Pubblicazione: (2024)
• Analytical Quality by Design Enabled Green RP‐HPLC Method Development and Validation for the Simultaneous Quantitation of the Cleaning Residues of Osimertinib, Binimetinib, and Erdafitinib: An Approach to Prevent the Cross‐Contamination in Shared Facilities of Pharmaceutical Manufacturing
  di: Jainendra Kumar Jain, et al.
  Pubblicazione: (2025)